Ongoing observational clinical research has prioritized understanding the human immune response to SARS-CoV-2 during the coronavirus disease 2019 (COVID-19) pandemic. Several recent studies suggest that immune dysregulation with early and prolonged adaptive immune system activation can result in cellular exhaustion. In this issue of the JCI, Files et al. compared cellular immune phenotypes during the first two months of COVID-19 in hospitalized and less severe, non-hospitalized patients. The authors utilized flow cytometry to analyze circulating peripheral blood mononuclear cells. Both patient cohorts maintained B and T cell phenotypes consistent with activation and cellular exhaustion throughout the first two months of infection. Additionally, follow-up samples from the non-hospitalized patient cohort showed that activation markers and cellular exhaustion increased over time. These findings illustrate the persistent nature of the adaptive immune system changes that have been noted in COVID-19 and suggest longer term effects that may shape the maintenance of immunity to SARS-CoV-2.
Philip A. Mudd, Kenneth E. Remy
Title and authors | Publication | Year |
---|---|---|
Involvement of oxidative stress in post-acute sequelae of COVID-19: clinical implications
Valente Coronel PM, Luiz Soares Basilio DC, Teixeira Espinoça I, Souza de Souza KF, Miranda Campos N, Seiji Nakano Ota R, Paredes-Gamero EJ, Wilhelm Filho D, Coimbra Motta-Castro AR, Trentin Perdomo R, Parisotto EB |
Redox Report : Communications in Free Radical Research | 2025 |
The role of immune activation and antigen persistence in acute and long COVID.
Opsteen S, Files JK, Fram T, Erdmann N |
Journal of investigative medicine : the official publication of the American Federation for Clinical Research | 2023 |
Gut Microbiota and Mitochondria: Health and Pathophysiological Aspects of Long COVID.
Ailioaie LM, Ailioaie C, Litscher G |
International journal of molecular sciences | 2023 |
Concurrent glomerular PCDH7 deposits in PLA2R-associated membranous nephropathy.
Fu N, Yuan S, Yang G, Li H, Wang T |
CEN Case Reports | 2023 |
Methylprednisolone Treatment Versus Standard Supportive Care for Adult COVID-19 Mechanically Ventilated, Acute Respiratory Distress Syndrome Patients
M Rahman, S Nair, M Din, M Dar, M Masood, A Menhali, M Nuaimi, J Sreedharan, H Gasmelseed, A Khan |
2022 | |
Stem cell therapy for COVID-19 pneumonia
M Kebria, P Milan, N Peyravian, J Kiani, S Khatibi, M Mozafari |
2022 | |
Immunosenescence and Altered Vaccine Efficiency in Older Subjects: A Myth Difficult to Change
T Fulop, A Larbi, G Pawelec, A Cohen, G Provost, A Khalil, G Lacombe, S Rodrigues, M Desroches, K Hirokawa, C Franceschi, J Witkowski |
Human vaccines | 2022 |
COVID-19 disease and immune dysregulation
Davitt E, Davitt C, Mazer MB, Areti SS, Hotchkiss RS, Remy KE |
Best practice & research. Clinical haematology | 2022 |
Defective antifungal immunity in patients with COVID-19
Morton CO, Griffiths JS, Loeffler J, Orr S, White PL |
Frontiers in immunology | 2022 |
CXCL10 levels at hospital admission predict COVID-19 outcome: hierarchical assessment of 53 putative inflammatory biomarkers in an observational study
NI Lorè, RD Lorenzo, PM Rancoita, F Cugnata, A Agresti, F Benedetti, ME Bianchi, C Bonini, A Capobianco, C Conte, A Corti, R Furlan, P Mantegani, N Maugeri, C Sciorati, F Saliu, L Silvestri, C Tresoldi, N Farina, LD Filippo, M Battista, D Grosso, F Gorgoni, CD Biase, AG Moretti, L Granata, F Bonaldi, G Bettinelli, E Delmastro, D Salvato, G Magni, M Avino, P Betti, R Bucci, I Dumoa, S Bossolasco, F Morselli, F Ciceri, P Rovere-Querini, CD Serio, DM Cirillo, AA Manfredi |
Molecular Medicine | 2021 |
Severe Acute Respiratory Syndrome–Associated Coronavirus 2 Infection and Organ Dysfunction in the ICU: Opportunities for Translational Research
PA Verhoef, S Kannan, JL Sturgill, EW Tucker, PE Morris, AC Miller, TR Sexton, JL Koyner, R Hejal, SC Brakenridge, LL Moldawer, RS Hotchkiss, TM Blood, MB Mazer, S Bolesta, SA Alexander, DL Armaignac, SL Shein, C Jones, CD Hoemann, A Doctor, SH Friess, RI Parker, AT Rotta, KE Remy |
2021 | |
Severe COVID-19 is characterized by the co-occurrence of moderate cytokine inflammation and severe monocyte dysregulation
B Bonnet, J Cosme, C Dupuis, E Coupez, M Adda, L Calvet, L Fabre, P Saint-Sardos, M Bereiziat, M Vidal, H Laurichesse, B Souweine, B Evrard |
EBioMedicine | 2021 |
Post‐surgical pyoderma gangrenosum in otherwise healthy patient with history of COVID‐19
MD Rich, TJ Sorenson, W Schubert |
The Breast Journal | 2021 |
Asymptomatic and Mild SARS-CoV-2 Infections Elicit Lower Immune Activation and Higher Specific Neutralizing Antibodies in Children Than in Adults
MR Petrara, F Bonfante, P Costenaro, A Cantarutti, F Carmona, E Ruffoni, CD Chiara, M Zanchetta, L Barzon, D Donà, LD Dalt, A Bortolami, M Pagliari, M Plebani, P Rossi, N Cotugno, P Palma, C Giaquinto, AD Rossi |
Frontiers in immunology | 2021 |
Immunological Changes in Pregnancy and Its Relation to COVID-19 Infection
Hamza AS |
2021 |